Skip to main content
Log in

Adalimumab/methotrexate

Pulmonary tuberculosis and rise in transaminase levels: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Kaushik V, et al. Real-life safety profile of biosimilar adalimumab in patients with inflammatory arthritic conditions. Annals of the Rheumatic Diseases 76 (Suppl. 2): 561 abstr. FRI0209, Jun 2017. Available from: URL: http://doi.org/10.1136/annrheumdis-2017-eular.2357 [abstract] - India

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/methotrexate. Reactions Weekly 1697, 19 (2018). https://doi.org/10.1007/s40278-018-44575-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44575-0

Navigation